Lipid Updates From Spring 2019
Burden of Dyslipidemia in ASCVD
Lessons From Statin Trials
Nonstatin Strategies to Further Reduce LDL-C Ezetimibe
Nonstatin Strategies to Further Reduce LDL-C PCSK9 Inhibitors
Need for Effective Lipid-Lowering Therapy Beyond a Statin and Challenges Associated With Statin Therapy
Statins Foundation of Lipid-Lowering Therapy
Lessons Learned From the PCSK9 Inhibitor CV Outcomes Trials
PCSK9 Inhibitors are Efficient at Lowering LDL-C
PCSK9 Inhibitors Reduce CV Events
PCSK9 Inhibitors Are Safe
PCSK9 Inhibitors Reported a Clinical Benefit Associated With Very Low LDL-C Levels
Re-Evaluating LDL-C Targets
Lipid-Lowering Therapy
CLEAR Wisdom Trial Bempadoic Acid
CLEAR Wisdom Trial Results
ORION-4 Design
VESALIUS-CV Trial Design
Implications for Clinical Care
Identifying Which Patient Will Benefit Most From PCSK9 Inhibition
2018 Guidelines on the Management of Blood Cholesterol Secondary Prevention -- PCSK9 Inhibitors
Overcoming Access Barriers to PCSK9 Inhibitors
Abbreviations
Abbreviations (cont)